Titre : Complément C3c

Complément C3c : Questions médicales fréquentes

Termes MeSH sélectionnés :

Complement C4b
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Complément C3c : Questions médicales les plus fréquentes", "headline": "Complément C3c : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Complément C3c : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-04", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Complément C3c" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Complément C3b", "url": "https://questionsmedicales.fr/mesh/D003179", "about": { "@type": "MedicalCondition", "name": "Complément C3b", "code": { "@type": "MedicalCode", "code": "D003179", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.124.486.274.250.260" } } }, "about": { "@type": "MedicalCondition", "name": "Complément C3c", "alternateName": "Complement C3c", "code": { "@type": "MedicalCode", "code": "D015932", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Marinos C Dalakas", "url": "https://questionsmedicales.fr/author/Marinos%20C%20Dalakas", "affiliation": { "@type": "Organization", "name": "Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. mdalakas@med.uoa.gr." } }, { "@type": "Person", "name": "Shruti Chaturvedi", "url": "https://questionsmedicales.fr/author/Shruti%20Chaturvedi", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Robert A Brodsky", "url": "https://questionsmedicales.fr/author/Robert%20A%20Brodsky", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Keith R McCrae", "url": "https://questionsmedicales.fr/author/Keith%20R%20McCrae", "affiliation": { "@type": "Organization", "name": "Division of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH." } }, { "@type": "Person", "name": "Martin Kohn", "url": "https://questionsmedicales.fr/author/Martin%20Kohn", "affiliation": { "@type": "Organization", "name": "Institute of Medical Microbiology and Hospital Epidemiology, Medical School Hannover, Hannover, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Acute Antibody-mediated rejection in liver transplantation: Impact and applicability of the Banff working group on liver allograft pathology 2016 criteria.", "datePublished": "2022-06-18", "url": "https://questionsmedicales.fr/article/35728694", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.humpath.2022.06.015" } }, { "@type": "ScholarlyArticle", "name": "Recurrent IgA Nephropathy or Subclinical Chronic Humoral Rejection With Predominance of Plasma Cells: A Case Report.", "datePublished": "2024-02-10", "url": "https://questionsmedicales.fr/article/38342745", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.transproceed.2024.01.048" } }, { "@type": "ScholarlyArticle", "name": "Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37096730", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ctr.14997" } }, { "@type": "ScholarlyArticle", "name": "Systemic evaluation of lymphocyte-bound C4d and immunoglobulins for diagnosis and activity monitoring of systemic lupus erythematosus.", "datePublished": "2023-06-19", "url": "https://questionsmedicales.fr/article/37343744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.clinbiochem.2023.110600" } }, { "@type": "ScholarlyArticle", "name": "Cytoplasmic WT1 in IgA nephropathy, an indicator of poor prognosis associated with mesangial/peri-mesangial C4d.", "datePublished": "2022-08-29", "url": "https://questionsmedicales.fr/article/36036855", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11255-022-03357-4" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines du sang", "item": "https://questionsmedicales.fr/mesh/D001798" }, { "@type": "ListItem", "position": 5, "name": "Immunoprotéines", "item": "https://questionsmedicales.fr/mesh/D007162" }, { "@type": "ListItem", "position": 6, "name": "Protéines du système du complément", "item": "https://questionsmedicales.fr/mesh/D003165" }, { "@type": "ListItem", "position": 7, "name": "Complément C3", "item": "https://questionsmedicales.fr/mesh/D003176" }, { "@type": "ListItem", "position": 8, "name": "Complément C3b", "item": "https://questionsmedicales.fr/mesh/D003179" }, { "@type": "ListItem", "position": 9, "name": "Complément C3c", "item": "https://questionsmedicales.fr/mesh/D015932" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Complément C3c - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Complément C3c", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-08", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Complément C3c", "description": "Comment mesurer le complément C3c ?\nQuels tests sont associés au C3c ?\nQuand évaluer le C3c ?\nLe C3c est-il un marqueur de maladie ?\nQuel rôle joue le C3c dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Complément C3c", "description": "Quels symptômes sont liés à un faible C3c ?\nUn C3c élevé indique-t-il des symptômes ?\nLe C3c affecte-t-il la fatigue ?\nY a-t-il des symptômes spécifiques au C3c ?\nLe C3c est-il lié à des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Complément C3c", "description": "Comment prévenir les anomalies du C3c ?\nLe vaccin influence-t-il le C3c ?\nY a-t-il des habitudes à éviter ?\nLe stress affecte-t-il le C3c ?\nDes examens réguliers sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Complément C3c", "description": "Comment traiter un faible C3c ?\nDes médicaments affectent-ils le C3c ?\nLe C3c nécessite-t-il un suivi ?\nPeut-on augmenter le C3c naturellement ?\nLes transfusions affectent-elles le C3c ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Complément C3c", "description": "Quelles complications peuvent survenir avec un C3c bas ?\nUn C3c élevé cause-t-il des complications ?\nLe C3c affecte-t-il la guérison des blessures ?\nY a-t-il des risques de thrombose liés au C3c ?\nLe C3c influence-t-il les maladies cardiovasculaires ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Complément C3c", "description": "Quels facteurs augmentent le risque de C3c anormal ?\nL'âge influence-t-il le C3c ?\nLe sexe joue-t-il un rôle dans le C3c ?\nLe mode de vie affecte-t-il le C3c ?\nLes antécédents familiaux influencent-ils le C3c ?", "url": "https://questionsmedicales.fr/mesh/D015932?mesh_terms=Complement+C4b&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer le complément C3c ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le complément C3c est mesuré par un test sanguin spécifique en laboratoire." } }, { "@type": "Question", "name": "Quels tests sont associés au C3c ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de C3c sont souvent associés à des dosages de C3 et C4." } }, { "@type": "Question", "name": "Quand évaluer le C3c ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Le C3c est évalué lors de suspicion de maladies auto-immunes ou inflammatoires." } }, { "@type": "Question", "name": "Le C3c est-il un marqueur de maladie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de C3c peuvent indiquer des pathologies sous-jacentes." } }, { "@type": "Question", "name": "Quel rôle joue le C3c dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le C3c aide à évaluer l'activité du système du complément dans diverses conditions." } }, { "@type": "Question", "name": "Quels symptômes sont liés à un faible C3c ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Un faible C3c peut entraîner des infections fréquentes et des inflammations." } }, { "@type": "Question", "name": "Un C3c élevé indique-t-il des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Un C3c élevé peut être associé à des symptômes d'inflammation ou d'infection." } }, { "@type": "Question", "name": "Le C3c affecte-t-il la fatigue ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux de C3c peuvent contribuer à la fatigue liée à l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques au C3c ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, le C3c n'a pas de symptômes spécifiques, mais reflète l'état immunitaire." } }, { "@type": "Question", "name": "Le C3c est-il lié à des douleurs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de C3c peuvent être associés à des douleurs inflammatoires." } }, { "@type": "Question", "name": "Comment prévenir les anomalies du C3c ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir un mode de vie sain et gérer les maladies chroniques aide à prévenir les anomalies." } }, { "@type": "Question", "name": "Le vaccin influence-t-il le C3c ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins peuvent stimuler le système immunitaire, influençant potentiellement le C3c." } }, { "@type": "Question", "name": "Y a-t-il des habitudes à éviter ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et une mauvaise alimentation peut aider à maintenir un C3c normal." } }, { "@type": "Question", "name": "Le stress affecte-t-il le C3c ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber le système immunitaire et affecter le C3c." } }, { "@type": "Question", "name": "Des examens réguliers sont-ils nécessaires ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens réguliers peuvent aider à détecter des anomalies du C3c tôt." } }, { "@type": "Question", "name": "Comment traiter un faible C3c ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente, souvent par immunothérapie." } }, { "@type": "Question", "name": "Des médicaments affectent-ils le C3c ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments immunosuppresseurs peuvent réduire les niveaux de C3c." } }, { "@type": "Question", "name": "Le C3c nécessite-t-il un suivi ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier est recommandé pour surveiller les niveaux de C3c." } }, { "@type": "Question", "name": "Peut-on augmenter le C3c naturellement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent soutenir le système immunitaire." } }, { "@type": "Question", "name": "Les transfusions affectent-elles le C3c ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les transfusions peuvent influencer les niveaux de C3c en fonction des composants." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un C3c bas ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Un C3c bas peut entraîner des infections récurrentes et des maladies auto-immunes." } }, { "@type": "Question", "name": "Un C3c élevé cause-t-il des complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un C3c élevé peut être lié à des complications inflammatoires et des maladies chroniques." } }, { "@type": "Question", "name": "Le C3c affecte-t-il la guérison des blessures ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux de C3c peuvent retarder la guérison en perturbant l'inflammation." } }, { "@type": "Question", "name": "Y a-t-il des risques de thrombose liés au C3c ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de C3c peuvent être associés à un risque accru de thrombose." } }, { "@type": "Question", "name": "Le C3c influence-t-il les maladies cardiovasculaires ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de C3c peuvent être liés à un risque accru de maladies cardiovasculaires." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de C3c anormal ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies auto-immunes, infections chroniques et certains médicaments augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le C3c ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge peut affecter les niveaux de C3c, souvent en raison de changements immunitaires." } }, { "@type": "Question", "name": "Le sexe joue-t-il un rôle dans le C3c ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des différences hormonales peuvent influencer les niveaux de C3c entre les sexes." } }, { "@type": "Question", "name": "Le mode de vie affecte-t-il le C3c ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent affecter le C3c." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le C3c ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies immunitaires peuvent augmenter le risque de C3c anormal." } } ] } ] }

Sources (1620 au total)

Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements.

Acute antibody mediated rejection is increasingly identified in liver allografts as a unique form of alloimmune injury associated with donor specific antibodies (DSA). This manifests pathologically as... In this blinded control study, we evaluated CD163 immunohistochemistry and applied the Banff 2016 criteria for diagnosis of acute AMR on a group of indication allograft liver biopsies from DSA positiv... Most DSA positive patients were females (75%, p = .027), and underwent transplantation for HCV infection. Significant histopathological predictors of serum DSA positivity were Banff H-score (p = .01),... Sinusoidal CD163, Banff H-score, and diffuse C4d are predictors of serum DSA, and facilitate recognition of histopathological features associated with serum DSA and tissue-antibody interaction....

Systemic evaluation of lymphocyte-bound C4d and immunoglobulins for diagnosis and activity monitoring of systemic lupus erythematosus.

To investigate the role of lymphocyte-bound C4d (LB-C4d: T-C4d, B-C4d) and immunoglobulins (LB-Igs: T-IgG, T-IgM, B-κ and B-λ) in the diagnosis and monitoring of SLE.... The levels of C4d and Igs on peripheral lymphocytes were measured in 172 patients with SLE, 174 patients with other non-SLE inflammatory diseases and 100 healthy individuals. Immunobinding and blockin... Patients with SLE had the highest median LB-C4d/Igs levels. LB-C4d had a significant but weak positive association with LB-Igs, with correlation coefficients ranging from 0.008 to 0.316. Anti-cardioli... Both autoantibodies and receptors on lymphocytes contribute to LB-C4d/Igs formation. LB-C4d/Igs could be used as reliable indicators for SLE diagnosis and activity monitoring....

Cytoplasmic WT1 in IgA nephropathy, an indicator of poor prognosis associated with mesangial/peri-mesangial C4d.

We aimed to investigate the immuno-histochemical expression of C4d, ADAM10 and WT1 in kidney biopsies of immunoglobulin A nephropathy (IgAN) patients and correlate the findings with clinical, laborato... Paraffin-embedded kidney biopsy samples of 128 IgAN patients were immuno-histochemically treated with C4d and ADAM10/WT1 dual stain. Results were evaluated according to Oxford classification parameter... We observed C4d positivity in 40.6% of our patients, 25% of which was mesangial/peri-mesangial (m/pm) staining. Only m/pmC4d positivity statistically correlated with progression to end-stage renal dis... This study is the first to show that cWT1is involved in IgAN and appears as an independent variable for worse prognosis....

Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases.

Detecting low viral load has been a challenge in this pandemic, which has led to its escalated transmission. Complement activation has been implicated in pathogenesis of Covid-19 infection. Thus, eval... Plasma C4b levels of symptomatic RT-PCR positive patients (cases, n = 40); symptomatic RT-PCR negative patients (n = 35) and asymptomatic RT-PCR negative controls (n = 40) were evaluated. Plasma C5b-9... C4b levels were found to be significantly increased in RT-PCR positive patients as compared to asymptomatic RT-PCR negative controls. RT-PCR negative but symptomatic patients still showed increased C4... The results of our study suggests that plasma C4b may help to detect infection in false negative cases of RT-PCR that escape detection owing to low viral load. However, to confirm it a large-scale stu... The online version contains supplementary material available at 10.1007/s12291-022-01033-z....

Myeloperoxidase Staining Identifies Endothelial Injury of Peritubular Capillaries and Glomeruli in Renal Antibody-Mediated Rejection.

It remains unclear if C4d staining is related to any peritubular and glomerular injury during antibody mediated rejection (ABMR). The goal of this study was to determine if myeloperoxidase (MPO) stain... The study included 12 native negative controls, 19 transplant biopsies with borderline changes (BC) as transplant controls, and one group of renal transplant biopsies with ABMR as the study group (acu... The negative control group and the transplant controls showed no MPO expression in the endothelium of glomeruli and PTC. However, in the biopsies with ABMR, there were MPO-positive stains in the endot... Our data suggest that the MPO-positive endothelial injuries are most likely the cause leading to renal graft dysfunction following ABMR....

Complement.

The role of complement in human autoimmune, inflammatory, and infectious diseases is reviewed, focusing on clinical applicability. A typical case is presented in which serum testing for C3 and C4 is p...